文献速递糖尿病肥胖与代谢综合征

新诊断2型糖尿病早期血糖暴露与癌症风险

Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes.
PubMed 文献 · Diabetologia · 2026-06-05

该回顾性队列研究纳入52,926例香港华人新诊断2型糖尿病患者,分析时间加权平均HbA1c与癌症风险的关系。结果显示,HbA1c每升高11 mmol/mol(1%),任何部位癌症风险相对增加27%(HR 1.27;95%CI 1.20,1.33);诊断后前2年HbA1c≥53 mmol/mol(≥7.0%)者癌症风险较<53 mmol/mol者相对高30-75%,且早期高HbA1c暴露对癌症风险贡献更大。

要点

  • 新诊断2型糖尿病总体高血糖暴露与长期癌症风险升高相关。
  • 诊断后前2年HbA1c≥7.0%与任何部位癌症风险相对增加30-75%相关。
  • 早期(1-2年)HbA1c降低1%与10年窗口内癌症风险相对降低6%相关。

核心结论

  • 总体高血糖暴露与新诊断2型糖尿病患者的长期癌症风险升高相关。
  • 诊断后早期血糖管理更好者,尽管总体血糖负担相当,癌症风险低于后期才改善血糖者。

研究设计与样本

  • 回顾性分析香港地区52,926例新诊断2型糖尿病华人队列。
  • 按随访期间时间加权平均HbA1c分组分析癌症风险(n=49,978)。
  • 按特定早期暴露期分组分析(n=39,185),并采用加权累积暴露模型(n=49,966)。

主要发现

  • 49,978例中发生1758例癌症事件。
  • 时间加权平均HbA1c每升高11 mmol/mol(1%),任何部位癌症风险相对增加27%(HR 1.27;95%CI 1.20,1.33)。
  • 诊断后前2年,时间加权平均HbA1c≥53 mmol/mol(≥7.0%) vs <53 mmol/mol(<7.0%)与任何部位癌症风险相对增加30-75%相关,取决于具体HbA1c类别,调整后续HbA1c后仍存在。
  • 早期暴露持续时间越长风险越高,前5年暴露达51-213%。
  • 较早的高HbA1c暴露比较晚暴露对癌症风险贡献更强。

临床怎么用

  • 对新诊断2型糖尿病患者应重视诊断后早期血糖控制,以可能降低长期癌症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to determine whether overall and time-specific patterns of hyperglycaemia, particularly soon after diagnosis, are associated with incident cancer in adults with newly diagnosed type 2 diabetes. METHODS: We retrospectively analysed a territory-wide cohort of 52,926 Hong Kong Chinese people with newly diagnosed type 2 diabetes. We examined cancer risk across groups of individuals classified according to their time-weighted mean HbA1c over the entire follow-up period (n=49,978) or during specific early exposure periods (n=39,185). A weighted cumulative exposure model was used to determine the role of historical HbA1c exposures in cancer development (n=49,966). RESULTS: Among 49,978 individuals with newly diagnosed type 2 diabetes, 1758 cancer events occurred. Each 11 mmol/mol (1%) increase in time-weighted mean HbA1c was associated with a 27% relative higher risk of cancer at any site (HR 1.27; 95% CI 1.20, 1.33). Within the first 2 years after diagnosis, a time-weighted mean HbA1c ≥53 mmol/mol (≥7.0%) vs <53 mmol/mol (<7.0%) was associated with a 30-75% relative higher risk of cancer at any site, depending on the specific HbA1c category, even after adjusting for subsequent HbA1c. Longer durations of early exposure were associated with higher risk, reaching 51-213% in the first 5 years of exposure. Earlier high HbA1c exposures contributed more strongly to cancer risk than later exposures. A 11 mmol/mol (1%) HbA1c reduction at 1-2 years was associated with a 6% relative lower cancer risk over a hypothetical 10 year window (HR 0.94; 95% CI 0.91, 0.98), whereas reductions after 5 years showed no significant risk differences. CONCLUSIONS/INTERPRETATION: Overall, hyperglycaemic exposure was associated with an elevated long-term cancer risk in type 2 diabetes. Notably, individuals who showed better glycaemic management soon after diagnosis exhibited a lower cancer risk than those whose glycaemic management improved later, despite comparable overall glycaemic burdens.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Zhang X, Yang A, Wu H, et al. Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes. Diabetologia. 2026. PMID: 42247170. doi:10.1007/s00125-026-06758-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。